Published in Science on October 24, 1969
Postpartum haemolytic-uraemic syndrome successfully treated with antithrombin III. Br Med J (1980) 0.75
A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells. Transplantation (1970) 4.35
The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 3.88
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today (1994) 2.81
Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet (2001) 2.64
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods (2000) 2.22
The frequency of antigen-sensitive cells in tissue transplantation. A commentary on clonal selection. J Exp Med (1969) 2.15
The elusive T cell receptor. Transplant Rev (1972) 2.14
[Venous thromboembolism--incidence and risk factors in Oslo]. Tidsskr Nor Laegeforen (1998) 2.03
Gains and losses of warfarin therapy as performed in an anticoagulation clinic. J Intern Med (2006) 2.02
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 1.98
MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity (2001) 1.84
Total immunoglobulin of rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 1.84
Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods (1981) 1.83
Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol (1997) 1.81
Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol (1998) 1.74
The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol (2001) 1.59
The property of "strength" of histocompatibility antigens, and their ability to produce antigenic competition. Transplantation (1967) 1.58
Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med (2000) 1.56
Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol (2006) 1.51
An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods (2001) 1.50
Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH). Thromb Res (1977) 1.46
The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens. Proc Natl Acad Sci U S A (1986) 1.44
Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol (2005) 1.44
Heparin induces release of extrinsic coagulation pathway inhibitor (EPI). Thromb Res (1988) 1.43
Heparin cofactor activity measured with an amidolytic method. Thromb Res (1975) 1.42
Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin. Eur Heart J (1993) 1.42
The anticoagulant effect of heparan sulfate and dermatan sulfate. Thromb Res (1976) 1.41
[Alcohol abuse as the cause of admission to a medical department]. Tidsskr Nor Laegeforen (1990) 1.39
Structure and homology of human C1q receptor (collectin receptor). Immunology (1993) 1.37
Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol (1985) 1.34
Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol (2000) 1.34
Semen analysis performed by different laboratory teams: an intervariation study. Int J Androl (1997) 1.30
Synthetic polypeptide metabolism. 3. Degradation and organ localization of isomeric synthetic polypeptide antigens. J Immunol (1967) 1.28
Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol (2000) 1.28
In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin. Scand J Immunol (1990) 1.28
Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol (1966) 1.26
Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods Enzymol (1981) 1.26
Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J Biol Chem (2001) 1.26
Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. Scand J Haematol (1970) 1.22
M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol (2005) 1.22
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease. Ann Intern Med (2001) 1.21
Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma. Scand J Clin Lab Invest (1970) 1.21
Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS (1993) 1.21
Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res (1976) 1.18
Structure and anticoagulant activity of a fucosylated chondroitin sulfate from echinoderm. Sulfated fucose branches on the polysaccharide account for its high anticoagulant action. J Biol Chem (1996) 1.18
Cisplatin nephrotoxicity. A review. Cancer Chemother Pharmacol (1989) 1.16
Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood (1996) 1.16
Bed rest and increased diuretic treatment in chronic congestive heart failure. Eur Heart J (1985) 1.14
The T lymphocyte antigen receptor--paradigm lost. Nature (1982) 1.13
Binding of thrombin to antithrombin III. Scand J Clin Lab Invest (1969) 1.12
Primary immune response in grafted cells. Dissociation between the proliferation of activity and the proliferation of cells. J Exp Med (1967) 1.11
Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol (2001) 1.10
Nomenclature for chicken major histocompatibility (B) complex. Immunogenetics (1982) 1.08
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun (2007) 1.08
Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol (2001) 1.08
Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol (1992) 1.08
The effect of different sulfonamides on phenytoin metabolism in man. Acta Med Scand Suppl (1979) 1.07
Purification and characterization of two mannan-binding lectins from mouse serum. J Immunol (2000) 1.07
Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin. Biochem J (1993) 1.07
The mannan-binding-lectin pathway of the innate immune response. Curr Opin Immunol (2001) 1.06
A simple and reliable method for the drying of polyacrylamide slab gels. J Biochem Biophys Methods (1982) 1.06
Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand J Immunol (1986) 1.06
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera. Clin Exp Immunol (1983) 1.06
Anticoagulant activity of heparin: assay of bovine, human and porcine preparations by amidolytic and clotting methods. Thromb Res (1977) 1.06
Highly purified antithrombin 3 with heparin cofactor activity prepared by disc electrophoresis. Scand J Clin Lab Invest (1968) 1.06
Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol (1999) 1.05
Humoral immunity to dietary antigens in healthy adults. Occurrence, isotype and IgG subclass distribution of serum antibodies to protein antigens. Int Arch Allergy Appl Immunol (1985) 1.05
Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19. J Immunol (2000) 1.04
Possible roles of compound membrane receptors in the immune system. Ann Immunol (Paris) (1983) 1.03
Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238). Thromb Res (1978) 1.03
Compound receptors in the cell membrane: ruminations from the borderland of immunology and physiology. Prog Allergy (1985) 1.03
Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol (2004) 1.02
Assay of progressive antithrombin in plasma. Thromb Diath Haemorrh (1970) 1.02
Mannan-binding lectin deficiency is associated with unexplained recurrent miscarriage. Scand J Immunol (1999) 1.02
The factor of immunization in the rat. The effect of allogeneic immunization on graft-versus-host activity. J Exp Med (1971) 1.02
Control of the classical and the MBL pathway of complement activation. Mol Immunol (2000) 1.02
Purification and characterization of a bovine serum lectin (CL-43) with structural homology to conglutinin and SP-D and carbohydrate specificity similar to mannan-binding protein. J Biol Chem (1993) 1.01
Pollen grains bind to lung alveolar type II cells (A549) via lung surfactant protein A (SP-A). Biosci Rep (1993) 1.01
The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol (2006) 1.00
Influence of major surgery on the mannan-binding lectin pathway of innate immunity. Clin Exp Immunol (2006) 0.99
Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin Exp Immunol (2005) 0.99
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res (1989) 0.98
The effect of antithrombin III on the activity of the coagulation factors VII, IX and X. Thromb Haemost (1976) 0.98
Renal tubular function in patients treated with high-dose cisplatin. Clin Pharmacol Ther (1988) 0.98
Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components. Clin Exp Immunol (2012) 0.97
Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest (1982) 0.97
Mannan-binding protein and bovine conglutinin mediate enhancement of herpes simplex virus type 2 infection in mice. Scand J Immunol (1994) 0.96
MHC-like molecules in some nonmammalian vertebrates can be detected by some cross-reactive xenoantisera. J Immunol (1990) 0.96
Recombinant expression of human mannan-binding lectin. Int Immunopharmacol (2001) 0.96
Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol (1995) 0.96
Pleiotropic effects of antithrombin strand 1C substitution mutations. J Clin Invest (1992) 0.95
On the nature and measurement of antigenic strength. Transplant Rev (1969) 0.95
Molar antithrombin concentration in normal human plasma. Haemostasis (1983) 0.95
The chicken erythrocyte-specific MHC antigen. Characterization and purification of the B-G antigen by monoclonal antibodies. Immunogenetics (1987) 0.95
Mannan-binding lectin in human serum, cerebrospinal fluid and brain tissue and its role in Alzheimer's disease. Neuroreport (1998) 0.94
MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway. Immunobiology (1998) 0.94
Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol (2004) 0.94
Antifactor Xa activity measured with amidolytic methods. Haemostasis (1976) 0.93
Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c. Immunology (1994) 0.93